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a b s t r a c t
The skin is the ﬁrst barrier against foreign pathogens and the prenatal formation of a strong network of
various innate andadaptive cells is required toprotect thenewborn fromperinatal infections.Whilemany
studies about the immune system in healthy and diseased adult human skin exist, our knowledge about
the cutaneous prenatal/developing immune system and especially about the phenotype and function of
antigen-presenting cells such as epidermal Langerhans cells (LCs) in human skin is still scarce. It has been
shown previously that LCs in healthy adult human skin express receptor activator of NF-B (RANK), an
importantmoleculeprolonging their survival. In this study,we investigatedatwhichdevelopmental stage
LCs acquire this important molecule. Immunoﬂuorescence double-labeling of cryostat sections revealed
that LC precursors in prenatal human skin either do not yet [10–11 weeks of estimated gestational age
(EGA)] or only faintly (13–15 weeks EGA) express RANK. LCs express RANK at levels comparable to adult
LCs by the end of the second trimester. Comparablewith adult skin, dermal antigen-presenting cells at no
gestational age express this marker. These ﬁndings indicate that epidermal leukocytes gradually acquire
RANK during gestation – a phenomenon previously observed also for other markers on LCs in prenatal
human skin.
ors. P© 2015 The Auth
ntroduction
The receptor activator of nuclear factor-kappaB ligand
RANKL/CD254), its signaling receptor RANK/CD265 and the
ecoy receptor osteoprotegerin are members of the tumor necro-
is factor (TNF) and TNF-receptor superfamily (Sigl and Penninger,
014). RANKL is found on osteoblasts, basophils, activated kera-
inocytes and T cells, while RANK is constitutively expressed
n osteoclasts and dendritic cells (DCs) (Barbaroux et al., 2008;
uber et al., 2014; Kukita and Kukita, 2013; Leibbrandt and
enninger, 2008; Loser and Beissert, 2007). RANKL/RANK have
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multiple functions ranging from bone physiology, mammary gland
formation, lymph node development, initiation of breast cancer
and immune regulation (Arizon et al., 2012; Beristain et al., 2012;
Hanada et al., 2011; Kukita and Kukita, 2013; Loser and Beissert,
2007; Sigl and Penninger, 2014).
Langerhans cells (LCs) represent the DC subset in the epider-
mis and other stratiﬁed epithelia. Under steady-state conditions
LCs have been implicated to maintain tolerance (Seneschal et al.,
2012). Upon infectious challenge they can drive T helper (TH) TH1,
TH2 (Furio et al., 2010), TH17 (Mathers et al., 2009) and TH22
(Fujita et al., 2009) responses. In healthy adult human epider-
mis, ∼95% of LCs express RANK when analyzed by ﬂow cytometry
(Barbaroux et al., 2008) while keratinocytes express low levels
of RANKL. Upon ultraviolet irradiation or infection of the skin in
mice, keratinocytes upregulate RANKL and trigger RANK express-
ing LCs (Loser et al., 2006; Yamaguchi and Sakaguchi, 2006). The
activated LCs produce cytokines [interleukin (IL)-6, IL-10, TNF-],
upregulate costimulatory molecules (CD86, CD205) and preferen-
tially induce theproliferation of CD4+CD25+ regulatory T cells (Treg)
which are able to suppress local and systemic immune reactions
(Loser et al., 2006). Similarly, transgenic mice expressing RANKL
under the keratinocyte-speciﬁc K14 promotor have increased Treg
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umbers in peripheral lymphoid organs which can subsequently
educe and delay the onset of CD40L-induced autoimmune der-
atitis in mice (Loser et al., 2006). Depletion of RANKL in mice
esults in a decrease of LC numbers as well as their proliferation
ate without affecting morphology (Barbaroux et al., 2008).
During prenatal human skin development, LC precursors start
o populate the epidermis at 7–8 weeks estimated gestational age
EGA). The LC phenotype is acquired in a step-wise manner start-
ng with human leukocyte antigen (HLA) class II followed by CD1c,
D207 and CD1a (Elbe-Bürger and Schuster, 2010; Foster et al.,
986; Fujita et al., 1991; Schuster et al., 2009, 2014). At 18 weeks of
estation, the marker proﬁle is similar to that of adult LCs express-
ng CD1a, CD1c, CD39, CD207, CCR6, CD324, and HLA class I and II
Elbe-Bürger and Schuster, 2010). The purpose of this study was to
xamine at which developmental stage LCs acquire RANK expres-
ion.
aterials and methods
Embryonic and fetal human skin was obtained from legal abor-
ions, ranging between 10 and 23weeks EGA (n=12). Healthy adult
uman breast and belly skin (25–60 years; n=7)was obtained after
lastic surgery. The studywas approvedby the local ethics commit-
ee and conducted in accordance with the Declaration of Helsinki
rinciples. The parents and adult volunteers were informed and
ave their written permission.
Skin specimens were cut into small pieces, embedded in
issue-Tek® optimumcutting temperature formulationcompound,
nap-frozen in liquid nitrogen and stored at −80 ◦C. Frozen sections
5m) of skin were cut, ﬁxed in ice-cold acetone, air-dried and
tained.
To prepare epidermal sheets from adult human skin, the sub-
utaneous tissue was removed, the remaining skin cut into small
ieces (∼1 cm2) andﬂoateddermal sidedownona3.8%ammonium
hiocyanate solution (Merck, Darmstadt) (1h, 37 ◦C). Subsequently,
pidermal sheets were carefully peeled from the dermis using for-
eps, washed with phosphate-buffered saline (pH 7.4; 2× 5min
ach), ﬁxed with acetone (10min, room temperature), washed
gain and either stained immediately as described below or stored
n Eppendorf tubes at −80 ◦C until use.
Skin sections and epidermal sheets were incubated with an
nconjugated anti-RANK mAb (clone 80704; R&D Systems, Min-
eapolis, MN) in 2% bovine serum albumin/phosphate-buffered
aline and subsequently stained with an Alexa Fluor 546-labeled
eagent (Invitrogen, San Diego, CA). In the next step mAbs against
ither HLA-DR (clone L243; FITC-labeled, BD Pharmingen, San
iego, CA) or CD1a (clone HI149; Alexa Fluor 488-labeled, Biole-
end, San Diego, CA) were applied. Finally, the samples were
ashed twice and a nuclear staining was performed with Hoechst
ye (Invitrogen). Control samples were stained with appropri-
te isotype-matched Ab. HLA-DR+RANK+ and HLA-DR+RANK− cells
n human epidermis have been enumerated on cryostat sections
nd placed in relation to the length of the epidermis (Olympus
X70, Olympus Corp., Tokyo). Single and double positive cells were
ounted in cryosections and epidermal sheets. Differences between
roups were assessed with Student’s t-test (GraphPad Software,
an Diego, CA). The reported p-value is a result of a two-sided test.
p-value <5% is considered statistically signiﬁcant.
esultshe majority of LCs in adult human epidermis express RANK
Double immunoﬂuorescence staining of healthy adult human
kin using cryostat sections and epidermal sheets revealed that LCsica 117 (2015) 425–430
co-express HLA-DR, CD1a and RANK (Fig. 1A–C) conﬁrming previ-
ously reported results (Barbaroux et al., 2008). Whereas HLA-DR is
expressed on epidermal LCs, dermal antigen-presenting cells and
endothelial cells, RANK expression in adult skin is conﬁned to LCs.
Based on previous ﬁndings which report that not all LCs express
RANK when evaluating single cell suspensions by ﬂow cytometry
(Barbaroux et al., 2008), it was our goal to investigate whether it is
possible to detect CD1a+RANK− cells in situ as well. We employed
the epidermal sheet staining method as it allows en face view of
the whole LC network in a given area compared to the few LCs in a
cryostat section.When comparatively analyzing skin fromdifferent
bodyregions,we found that thegreatmajorityof LCsexpressesboth
CD1a and RANK. In addition, we always detected a small but dis-
tinct population of CD1a+RANK− cells with a dendritic morphology
(Fig. 1C, insert), supplementingpreviously reportedﬂowcytometry
data (Barbaroux et al., 2008). In contrast to CD1a, RANK expression
is essentially conﬁned to the perinuclear cytoplasm and is conse-
quently only faintly or not expressed on dendrites. Furthermore,
we found that RANK is weakly expressed in some LCs implying
either a continuum of RANKlow to RANKhigh or vice versa in adult
skin (Fig. 1A,B). When enumerating CD1a+RANK− LCs in epidermal
sheets, we found that a comparable percentage of CD1a+ LCs in
breast, back, and abdominal skin failed to express RANK, indicat-
ing that CD1a+RANK− cells are similarly distributed in the analyzed
body locations (data not shown).
LC precursors in prenatal human skin acquire RANK in a
gradual manner
As RANK is (i) an important LC survival factor, (ii) a medi-
ator for cell differentiation and (iii) not expressed in all LCs in
adult epidermis (Fig. 1 and Barbaroux et al., 2008), we investi-
gated its expression in human prenatal skin to evaluate when
LC precursors start to express this molecule. HLA-DR is the ﬁrst
antigen-presenting cell speciﬁc marker to be found in embryonic
human skin (Foster et al., 1986 Schuster et al., 2009), andwas there-
fore employed to identify leukocyte precursors in prenatal skin. As
shown in Fig. 2, double immunoﬂuorescence staining of cryostat
sections conﬁrmed the presence of some rare HLA-DR+ epidermal
(insert) anddermal (arrow) leukocytesnoneofwhichexpressRANK
at 10 and 11 weeks EGA. At 13 weeks EGA, we found that some but
not all HLA-DR+ cells in the epidermis express low levels of RANK
(Fig. 2, arrow and insert). Surprisingly, we detected strong RANK
expression in the periderm – a development-speciﬁc cell layer – at
this time point of gestation (Fig. 2).With advancing gestational age,
we found a spectrum of RANKlow–high leukocytes (data not shown)
reaching adult-like staining intensity levels at 19–23 weeks EGA
(Fig. 2, insert) while the density of RANK+ cells in fetal epidermis
is not yet comparable to that in adults (10 vs. 75 cells/5000m
epidermis) (Fig. 3). HLA-DR+ dermal cells at no time point of inves-
tigation express RANK. Statistical analysis revealed that in ﬁrst
trimester skin 67.7% [standard deviation (SD) 28.0%, n=3] of all
HLA-DR+ epidermal cells lack expression of RANK. The frequency
of HLA-DR+RANK− epidermal cells decreases with gestational age
to 13.0% (SD 12.1%, n=3) in second trimester skin and to 0.2% in
adult skin (SD 0.46%; n=3) (Fig. 3).
Discussion
In the current study we provide evidence that LCs undergo a
transition regarding the expression of RANK in healthy skin during
gestation. We found a major population of HLA-DR+RANK− epider-
mal leukocytes and a minor population of HLA-DR+RANK+ cells in
embryonic epidermis. Later during development, RANK+ epider-
mal leukocytes outnumber RANK− cells. We also identiﬁed a small
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Fig. 1. Not all LCs express RANK in adult human skin in situ. Immunoﬂuorescence double-labeling was performed on cryostat sections of adult human skin and revealed the
presence of HLA-DR+RANK+ LCs in the epidermis (insert) and HLA-DR+RANK− cells in the dermis (A). One representative donor out of seven is shown. Double immunoﬂuo-


























mescence labeling of epidermal sheets showed that most, but not all, CD1a epiderm
ere stained with Hoechst dye. Scale bars: 50m (A, B), 100m (C).
opulation of CD1a+RANK− LCs in adult skin in situ supplementing
ublished ﬂow cytometry data (Barbaroux et al., 2008). However,
t is currently unclear whether these cells represent either RANK−
C precursors or LCs that have downregulated RANK. In addition,
lso CD1a−RANK+ epidermal cellswere described (Barbaroux et al.,
008). Their further characterization in our laboratory revealed
heir keratinocyte nature. Moreover we found that neither T cells
or melanocytes express RANK (Akgün, 2010).
In prenatal human skin, the leukocyte network has to develop
arly to ensure protection from the hostile milieu after birth
Schuster et al., 2012). Indeed, LC and dermal DC precursors popu-
ate the skin early during gestation and at around 18 weeks of EGA
hey already show the same marker proﬁle and are morphologi-
ally similar to adult LCs (Elbe-Bürger and Schuster, 2010 Foster
t al., 1986 Schuster et al., 2009). Key cytokines required for LC
evelopment, such as bone morphogenetic protein 7 (BMP7) and
ransforming growth factor beta-1 (TGF-1) are detectable in the
pidermis by 8 and 9 weeks EGA, respectively. Both molecules
how an inverse expression pattern in the stratiﬁed epidermis:
MP7 in the basal layer and TGF-1 exclusively in the suprabasal
ayer (Elbe-Bürger and Schuster, 2010 Yasmin et al., 2013). Dur-
ng maturation of the epidermis, TGF-1 production precedes the
cquisition of markers like Lag, CD207 and CD1a on LC precur-
ors at 12–13 weeks EGA (Schuster et al., 2009). Interestingly,
his also correlates with our ﬁndings that RANK expression com-
ences at around 13 weeks EGA, at the same time point whenlls co-express RANK (B, C). Shown is one representative donor out of seven. Nuclei
TGF- production starts to increase (Schuster et al., 2009). Further-
more, higher concentrations of proliferation-inducing cytokines
like IL-6, chemokine (C–C motif) ligand 5 (CCL5), stem cell fac-
tor (SCF) and granulocyte–macrophage colony-stimulating factor
(GM-CSF) are present in prenatal skin cell cultures compared to
those of adults, generating an environment conceivably attract-
ing the immigration of blood born precursors and promoting the
propagation of skin-resident leukocytes (Schuster et al., 2009). This
changing cytokine microenvironment within the developing skin
could also be a reason for the gradual acquisition of RANK in our
studies. We found that RANK expression besides cells of the peri-
derm was restricted to HLA-DR+ epidermal leukocytes at every
gestational step. The observations that LC precursors gradually
augment the intensity of RANK expression with increasing gesta-
tional age and that leukocytes in prenatal dermis never express this
marker imply that they acquire this marker in the epidermis. These
results conﬁrmed our previous ﬁndings showing that in foreskins
from infants and children the percentage of CD1a+RANK− epider-
mal cells is higher compared to adult foreskins (Akgün, 2010). In
conclusion, ourdataprovide furtherevidence thatbesidesHLAclass
II, CD1c, CD207 and CD1a also RANK/CD265 expression is acquired
in LC precursors upon their arrival in the microenvironment of the
skin.
It has been described that the secretion of the immunosup-
pressive cytokine IL-10 in gut DCs is initiated by RANK and
that RANK/RANKL interaction leads to oral tolerance (Summers
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Fig. 2. RANK is acquired in a stepwise manner during prenatal skin development. Immunoﬂuorescence double-labeling was performed on cryostat sections of embryonic,
fetal and adult human skin. Inserts indicate the acquisition of RANK expression on HLA-DR+ epidermal leukocytes during gestation compared to adult skin. Arrows mark
HLA-DR+RANK− cells in the dermis at 11 weeks EGA. Arrowheads indicate HLA-DR+RANK− cells in the epidermis at 13 weeks EGA, a time point when HLA-DR+RANKlow cells










ihree donors per age group were analyzed. The dotted lines represent the dermal–e
eLuca and Gommerman, 2012). Furthermore, the numbers and
he function of Treg cells during inﬂammation is regulated by
ANK signaling of LCs (Loser and Beissert, 2007). Various stud-
es have shown that the immune system in the human fetus is
ctively suppressed by a high number of Treg cells in the circula-
ion (Michaelsson et al., 2006 Tilburgs et al., 2008). In addition, high
evels of IL-10 can be found in amniotic ﬂuid (Cadet et al., 1995).
hese ﬁndings lead us to speculate that the interaction of RANK and
ts ligand could be involved in the IL-10 secretion by LC precursorsmal junction. Scale bars: 50m.
in developing skin. It has been suggested that this autocrine IL-10
secretion may prevent the LC precursor emigration out of the skin
and keep them in place. In addition, evidence exists that IL-10 is
a key factor to maintain tolerance during pregnancy (Elbe-Bürger
and Schuster, 2010).Collectively, these data show that similar to other well known
and important LC markers, RANK is acquired in LCs in a gradual
manner during skin development and provide further important
insight into human skin DC biology during gestation.
A. Schöppl et al. / Acta Histochem
Fig. 3. RANK expression on LC precursors arises early during skin development.
The numbers of HLA-DR+RANK+ and HLA-DR+RANK− cells have been enumerated
on cryostat sections of indicated age groups. Bars represent themean of investigated

















This studyprovides further evidence for the concept that already
n the prenatal skin epidermal leukocytes acquire markers that are




We thank C. Fiala and W. Eppel for the organization of prena-
al human skin samples, A. Stift for the provision of adult human
kin samples and M. Mildner for help and valuable discussions.
his work was supported by the following Austrian Science Fund
FWF) grants: P19474-B13 and DK W1248-B13 (Doctoral Program
Molecular, Cellular and Clinical Allergology”) .
eferences
kgün J. Differential expression of RANK on Langerhans cells and
CD45RA and CD45RO/CLA on T cells in developing human skin
after birth. University of Vienna; 2010, Diploma Thesis.
rizonM,Nudel I, SegevH,Mizraji G, ElnekaveM, FurmanovK, et al.
Langerhans cells down-regulate inﬂammation-driven alveolar
bone loss. Proc Natl Acad Sci U S A 2012;109:7043–8.
arbaroux JB, Beleut M, Brisken C, Mueller CG, Groves RW. Epi-
dermal receptor activator of NF-kappaB ligand controls Langer-
hans cells numbers and proliferation. J Immunol 2008;181:
1103–8.
eristain AG, Narala SR, Di Grappa MA, Khokha R. Homotypic RANK
signaling differentially regulates proliferation, motility and cell
survival in osteosarcoma and mammary epithelial cells. J Cell
Sci 2012;125:943–55.adet P, Rady PL, Tyring SK, Yandell RB, Hughes TK. Interleukin-10
messenger ribonucleic acid in human placenta: implications of
a role for interleukin-10 in fetal allograft protection. Am JObstet
Gynecol 1995;173:25–9.ica 117 (2015) 425–430 429
Elbe-Bürger A, Schuster C. Development of the prenatal cuta-
neous antigen-presenting cell network. Immunol Cell Biol
2010;88:393–9.
Foster CA, Holbrook KA, Farr AG. Ontogeny of Langerhans cells
in human embryonic and fetal skin: expression of HLA-
DR and OKT-6 determinants. J Invest Dermatol 1986;86:
240–3.
Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger
JG. Human Langerhans cells induce distinct I.L-22-producing
CD4+ cells lacking I.L-17 production. Proc Natl Acad Sci U S A
2009;106:21795–800.
Fujita M, Furukawa F, Horiguchi Y, Ueda M, Kashihara-Sawami M,
Imamura S. Regional development of Langerhans cells and for-
mation of Birbeck granules in human embryonic and fetal skin.
J Invest Dermatol 1991;97:65–72.
Furio L, Briotet I, Journeaux A, Billard H, Peguet-Navarro J. Human
langerhans cells aremore efﬁcient thanCD14(−)CD1c(+) dermal
dendritic cells at priming naive CD4(+) T cells. J Invest Dermatol
2010;130:1345–54.
Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM.
RANKL/RANK-beyond bones. J Mol Med (Berl) 2011;89:
647–56.
Huber C, Odermatt A, Hagmann B, Dahinden CA, Fux M. In human
basophils, IL-3 selectively induces RANKL expression that is
modulated by IgER-dependent and IgER-independent stimuli.
Allergy 2014;69:1498–505.
Kukita A, Kukita T. Multifunctional properties of RANKL/RANK in
cell differentiation, proliferation and metastasis. Future Oncol
2013;9:1609–22.
Leibbrandt A, Penninger JM. RANK/RANKL: regulators of
immune responses and bone physiology. Ann N Y Acad Sci
2008;1143:123–50.
Loser K, Beissert S. Dendritic cells and T cells in the reg-
ulation of cutaneous immunity. Adv Dermatol 2007;23:
307–33.
Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, et al. Epider-
mal RANKL controls regulatory T-cell numbers via activation of
dendritic cells. Nat Med 2006;12:1372–9.
Mathers AR, Janelsins BM, Rubin JP, Tkacheva OA, Shufesky WJ,
Watkins SC, et al. Differential capability of human cutaneous
dendritic cell subsets to initiate Th17 responses. J Immunol
2009;182:921–33.
Michaelsson J, Mold JE, McCune JM, Nixon DF. Regulation of
T cell responses in the developing human fetus. J Immunol
2006;176:5741–8.
Schuster C, Mildner M, Mairhofer M, Bauer W, Fiala C, Prior M, et al.
Human embryonic epidermis contains a diverse Langerhans cell
precursor pool. Development 2014;141:807–15.
SchusterC,VaculikC, FialaC,Meindl S, BrandtO, ImhofM,et al.HLA-
DR+ leukocytes acquire CD1 antigens in embryonic and fetal
human skin and contain functional antigen-presenting cells. J
Exp Med 2009;206:169–81.
Schuster C, Vaculik C, Prior M, Fiala C, Mildner M, Eppel W, et al.
Phenotypic characterization of leukocytes in prenatal human
dermis. J Invest Dermatol 2012;132:2581–92.
Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS.
Human epidermal Langerhans cells maintain immune homeo-
stasis in skin by activating skin resident regulatory T cells.
Immunity 2012;36:873–84.
SiglV, Penninger JM.RANKL/RANK– frombonephysiology tobreast
cancer. Cytokine Growth Factor Rev 2014;25:205–14.
Summers deLuca L, Gommerman JL. Fine-tuning of dendritic
cell biology by the TNF superfamily. Nat Rev Immunol
2012;12:339–51.
Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Klei-
jburg C, Scherjon SA, et al. Evidence for a selective migration of
4 tochem
Y
Yasmin N, Bauer T, Modak M, Wagner K, Schuster C, Köffel R, et al.30 A. Schöppl et al. / Acta His
fetus-speciﬁc CD4+CD25bright regulatory T cells from theperiph-
eral blood to the decidua in human pregnancy. J Immunol
2008;180:5737–45.
amaguchi T, Sakaguchi S. Skin controls immune regulators. Nat
Med 2006;12:1358–9.ica 117 (2015) 425–430Identiﬁcation of bone morphogenetic protein 7 (BMP7) as an
instructive factor for human epidermal Langerhans cell differ-
entiation. J Exp Med 2013;210:2597–610.
